Figure 1.

The study groups’ (A) body weights and (B) fasting blood glucose (FBG) levels at the end of 15 weeks. The diabetic groups treated with CNME or metformin increased in body weight and had reduced FBG levels compared to the untreated diabetic group. Data are presented as mean ± SEM (n = 12). ^ap < 0.05 vs. C group. ^bp < 0.05 vs. DM group. Non-diabetic control group: C; non-diabetic group treated with 500 mg/kg CNME: C + CNME; untreated diabetic group: DM; diabetic group treated with 300 mg/kg metformin: DM + Met; diabetic group treated with 500 mg/kg CNME: DM + CNME.